Zenas BioPharma, Inc. Balance Sheet
Zenas BioPharma, Inc.'s total assets for Q4 2025 were $383.64M, an increase of 19.14% from the previous quarter. ZBIO total liabilities were $141.50M for the fiscal quarter, a 12.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.